Eli Lilly and Livongo Health on Monday announced a collaborative effort to study real-world evidence to produce new insights in the fight against diabetes.
According to a press release, the partnership looks to “contribute medical literature” in the following areas:
- Measure the impact of remote diabetes self-management education and support on clinical and healthcare cost outcomes;
- Understand drivers of healthy behaviors; and
- Understand how people living with diabetes can stay more actively involved in their health.
“Collaborating with Livongo is an important step in our research efforts,” Lilly Diabetes Medical Affairs Vice President Sherry Martin said in a statement. “We hope our combined expertise will play a key role in empowering people with diabetes to better manage their condition.”